SEC 13F Intelligence

Sivik Global Healthcare LLC / REGN

Sivik Global Healthcare LLC’s Regeneron Pharmaceuticals Position

Does Sivik Global Healthcare LLC own Regeneron Pharmaceuticals (REGN)? Yes — 4.0K shares worth $3M (+2.35% of its 13F portfolio) as of Q1 2026, down from 160.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
4.0K
% of Portfolio
+2.35%
Quarters Held
11
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $5MQ2 ’19: $6MQ2 ’19Q3 ’19: $6MQ4 ’19: $8MQ4 ’19Q1 ’20: $5MQ2 ’20: $9MQ2 ’20Q3 ’20: $6MQ4 ’20: $10MQ4 ’20Q3 ’21: $6MQ1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.0K$3M+2.35%
Q3 2021160.0K$6M+1.38%
Q4 202020.0K$10M+3.94%
Q3 202010.0K$6M+2.41%
Q2 202015.0K$9M+3.10%
Q1 202010.0K$5M+1.93%
Q4 201920.0K$8M+2.79%
Q3 201920.0K$6M+2.80%
Q2 201920.0K$6M+1.51%
Q1 201913.0K$5M+1.97%
Q4 201810.0K$4M+2.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of REGN.